Hong Kong-listed Innovent Biologics Inc. is considering a licensing partnership to develop a cancer drug that’s showing ...

Pope Francis woke up Tuesday to good news from his doctors: They upgraded his prognosis and say he is no longer in imminent ...

BILLERICA — Billerica Memorial High School has announced its honor roll for the second term of the 2024-2025 school year.

Uncertainty around President Donald Trump’s tariff policies have sent the major averages on a roller-coaster ride and spurred ...

Eli Lilly stock has advanced more than 200% over the past three years thanks to the company’s dominance in the weight loss drug market. Lilly may face more competitors down the road in this high ...

Morgan Stanley analyst Terence Flynn notes that Novo Nordisk (NVO) reported CagriSema Phase 3 data in type two diabetes demonstrating weight ...

Eli Lilly plans to launch its blockbuster diabetes and weight-loss drug, Mounjaro, in countries like China, India, Brazil and Mexico in 2025, Chief Financial Officer Lucas Montarce said on Monday.

A new study of a migraine-specific tool reveals that patients are most concerned about misconceptions about migraine and the ...

Late-breaking results from Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) found adolescent patients (ages 12 to under 18) with severe alopecia areata (AA) treated with once-daily ...

See more HIMS analyst ratings Disclosure Questions or Comments about the article? Write to editor@tipranks.com Eli Lilly NewsMORE Related Stocks Indices ...